Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge Included in International Business Deal
Mandate

Vinge Included in International Business Deal

February 11, 2008

Vinge advises EQT on transfer of the Finnish Finn-Power Group to Prima Industries, listed in Italy. The transfer was resolved according to UK law. By the acquisition of the
Finn-Power Group Prima Industries will reach 50 countries which in turn will make Prima Industries the third largest producer of laser machines in the world. The group’s annual revenues are calculated to reach an estimated value of EUR 400 million.    

Cleary Gottlieb Steen & Hamilton represented the buyer and the Italian law firm Tosetto Weigmann e Associati handled the financing. Clifford Chance represented the Italian banks that financed the transfer and in addition to this assistance also came from the Finnish law firms Roschier, Hannes Snellman and Castrén & Snellman.   
 
Vinge’s team was co-ordinated by Anders Åberg and Tuula Tallavaara joined by James Hope, Petter Kjöllerström and Jenny Henriksson.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025